Stock BMRN BIOMARIN PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
80.91 USD -1.53% Intraday chart for BioMarin Pharmaceutical Inc. -8.71% -16.09%
Apr. 25 Scotiabank Adjusts Price Target on BioMarin Pharmaceutical to $85 From $83, Maintains Sector Perform Rating MT
Apr. 25 Wells Fargo Adjusts Price Target on BioMarin Pharmaceutical to $110 From $100, Maintains Overweight Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BMRN Stock
  4. Revisions BioMarin Pharmaceutical Inc.